In pituitary adenoma surgery, no vs. perioperative hydrocortisone was noninferior for new-onset adrenal insufficiency.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37011395.
- Also identified by DOI 10.7326/J23-0013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Guo X, Zhang D, Pang H, et al. <b>Safety of withholding perioperative hydrocortisone for patients with pituitary adenomas with an intact hypothalamus-pituitary-adrenal axis: a randomized clinical trial.</b> JAMA Netw Open. 2022;5:e2242221. 36383383.
Medical subject headings
- Adenoma
- Adrenal Insufficiency
- Pituitary Neoplasms